Jason R Becker

11PUBLICATIONS
43CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Molecular targetsMedical virologyAutonomic nervous systemStructural biology (incl. macromolecular modelling)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 04, 2026
The impact of non-cardiomyocyte MYBPC3 expression on the development of hypertrophic cardiomyopathy.

|Sep 15, 2025
Targeting Cardiomyocyte PCNA and POLD1 Prevents Pathologic Myocardial Hypertrophy.

Soumojit Pal, Michael S Glennon, Benjamin R Nixon

|May 09, 2025
Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial.

Constantin-Cristian Topriceanu, Christoffer Rasmus Vissing, Anna Axelsson Raja

|Aug 01, 2024
Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial.

Catherine G Ireland, Danielle S Burstein, Sharlene M Day

|Oct 27, 2023
MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy.

Puneeth Shridhar, Michael S Glennon, Soumojit Pal

|Jul 30, 2021
Cardiac natriuretic peptide deficiency sensitizes the heart to stress-induced ventricular arrhythmias via impaired CREB signalling.

Eric J Hall, Soumojit Pal, Michael S Glennon

Pageof 2

Frequent Collaborators

4 joint publications

Soumojit Pal

3 joint publications

Anjali T Owens

3 joint publications

Matthew T Wheeler

3 joint publications

Luisa Mestroni